About Artiria
Artiria is a company based in Lausanne (Switzerland) founded in 2019 by Marc Boers and Guillaume Petit Pierre. Artiria has raised $9.19 million across 9 funding rounds from investors including Zurcher Kantonalbank, European Union and 4FOX Ventures. Artiria offers products and services including SmartGUIDE. Artiria operates in a competitive market with competitors including Tobii Dynavox, Inscopix, Neurotrack, Brainomix and NovaSight, among others.
- Headquarter Lausanne, Switzerland
- Founders Marc Boers, Guillaume Petit Pierre
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Artiria Medical Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.19 M (USD)
in 9 rounds
-
Latest Funding Round
$500 K (USD), Debt – Conventional
Feb 28, 2024
-
Investors
Zurcher Kantonalbank
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Artiria
Artiria offers a comprehensive portfolio of products and services, including SmartGUIDE.
Enables precise navigation in neurovascular procedures.
People of Artiria
Unlock access to complete
Unlock access to complete
Funding Insights of Artiria
Artiria has successfully raised a total of $9.19M across 9 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $500 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Artiria
Artiria has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and 4FOX Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage investments in Swiss healthcare and technology are facilitated.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked |
Investor details for Artiria
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artiria
Investment portfolio details for Artiria
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Artiria
Detailed financials for Artiria
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artiria Comparisons
Peer comparison for Artiria
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artiria
Artiria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Inscopix, Neurotrack, Brainomix and NovaSight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| Locked | Locked | Locked |
Neurological disorders are diagnosed using eye-tracking assessment tools.
|
|
| Locked | Locked | Locked |
AI-powered imaging biomarkers are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Eye-tracking solutions for vision assessment and treatment are provided.
|
Detailed competitors of Artiria
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artiria
Complete news archive for Artiria
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artiria
Artiria was founded in 2019.
Artiria is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Guillaume Petit Pierre is the current CEO of Artiria. They have also founded this company.
Artiria is a funded company, having raised a total of $9.19M across 9 funding rounds to date.
Artiria Medical was founded in 2019 in Lausanne, Switzerland, within the medical technology sector. Micro-navigation technologies for brain surgeries are being developed, with a focus on stroke procedures. A minimally invasive navigation system has been created to support deep neurovascular navigation during surgical interventions. Operations center on advancing tools for precise guidance in neurosurgery, targeting improved procedural outcomes in neurovascular contexts.
Artiria's top competitors include NovaSight, Inscopix and Tobii Dynavox.
Artiria offers SmartGUIDE.
Artiria has 11 investors. Key investors include Zurcher Kantonalbank, European Union, 4FOX Ventures, Wyss Center for Bio and Neuroengineering, and Verve Ventures.